-
Anna Miltina Confronted with Racism Allegations on ProSieben Show
-
November Foraging Guide: Edible Mushrooms and Critical Safety Protocols
-
German Auto Giants Face Existential Crisis as China Sales Plummet
-
Microsoft Updates Xbox PC App with 60% Faster Startup and Redesigned Interface
-
Cause of Death Revealed for 'Ellen' Producer Matthew Wright
-
Early Polar Vortex Disruption Creates Uncertain Winter Outlook for Pennsylvania
-
How to Enjoy Luxury Experiences on a Budget
-
Edmund Richardson Wins Baillie Gifford Prize for 'Alexander' Biography
-
Pakistan Demands Grant-Based Climate Finance at COP31 to Avoid Debt Trap
-
BYD Drops Rotating Screens in New Models Due to Tech Limits
-
E Pellicci Pop-Up at Selfridges Brings Back Nostalgic School Cake
-
Ryanair Flight from Rome Makes Emergency Landing in Lisbon After Bomb Threat
-
Coronation Street's Debbie Webster Steps Down as Dementia Storyline Intensifies
Featured
Last news
NexTel Medical Corp. Clarifies and Expands Upon Remarks Made During Recent Online Discussion
ORLANDO, FL / ACCESS Newswire / August 6, 2026 / NexTel Medical Corp. (f/k/a Exousia Pro, Inc.) (OTCID:MAJI) ("NexTel" or the "Company") is issuing a clarification regarding statements made during an audio stream hosted yesterday afternoon with @SuperRobotGX.
Tenon Medical, Inc. Announces 1:35 Reverse Stock Split
LOS GATOS, CA / ACCESS Newswire / August 6, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced a 1-for-35 reverse stock split of the Company's issued and outstanding common stock.
Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing
Acquisition includes clinical-stage neuroplastogenic therapy with U.S. FDA Orphan Drug Designation for the treatment of Complex Regional Pain Syndrome (CRPS)Up to $77 million in private financing consisting of $21.5 million in private placement financing at initial close plus $17.1 million of Cy Biopharma's cash and cash equivalents from a pre-acquisition convertible note financing and up to $38.6 million upon achievement of clinical trial milestonePro forma cash expected to fund CY200 through Phase 2 proof-of-concept data and into registrational development
Who Does the Best Breast Reduction in Florida?
The Best Breast Reduction in Florida is Done by Dr. Sessa at Sarasota Surgical Arts
Nurses are Quitting Hospitals to Start Injecting Botox
AACM sees a surge in its online Botox course
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 06
Purchase of own shares
Guatemalan volcano eruption ends, locals return home
The eruption of Guatemala's Fuego volcano officially ended on Wednesday, the country's Institute of Volcanology reported.
Guatemala volcano eruption eases off, but alert remains in place
Activity at Guatemala's Fuego volcano died down slightly on Wednesday, after a powerful eruption of lava and ash forced hundreds of people to flee their homes.
Woman arrested after four men stabbed in central London
A woman was arrested after four men were stabbed Wednesday in Covent Garden, a busy central London area popular with tourists, in a suspected "mental health related incident", police said.
Where mountain lions roam, fewer deer in the headlights
Living among apex predators could make you safer.
Explosive drone found near Ukrainian plane at German airport
German police raised the alarm at an airport overnight after an explosives-laden drone was found near a Ukrainian cargo plane and another aircraft collided with an unknown flying object nearby before landing safely.
Pakistan team reaches base camp with body of renowned climber killed in avalanche
A search team has transported the bodies of renowned climber Nirmal Purja and three of his team members to the base camp of the mountain on which they were killed by an avalanche, the Alpine Club of Pakistan said Wednesday.
India monsoon floods, landslides kill more than 100 since July: officials
Floods and landslides triggered by monsoon rains have killed more than 100 people across India since July, official data showed Wednesday, with thousands forced to flee their inundated homes.
'Lost': Migrants despair after Britain expels them back to France
Former Afghan soldier Haidary Hamedullah risked his life to cross the Channel hoping for a brighter future for his family in Britain, but just weeks later UK authorities expelled him back to France.
Total eclipse gives scientists chance to probe Sun's mysteries
Scientists plan to use a total solar eclipse that will be visible in Spain next week as a rare chance to learn more about the stormy, unpredictable nature of our star.
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved productCompany expects supply to be available in select retailers in the coming weeks
Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity
Zomedica surpasses $9 million in second quarter revenue for the first time while extending its record of consecutive year-over-year revenue growth to 22 quarters.
Protagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update
ICOTYDE™ First Full Quarter of Commercial Sales with Strong Early AdoptionRusfertide NDA under Priority Review for Polycythemia Vera; PDUFA Date in August 2026Comprehensive Phase 2b Program with PN-881, an Oral IL-17 Antagonist for Psoriasis, Planned to Initiate Early Q1 2027Phase 1 Study Initiated with PN-477sc, a Triple GLP1/GIP/GCG Agonist Peptide for ObesityCash, Cash Equivalents and Marketable Securities of $849.5 Million as of June 30, 2026
Envela Reports Second Quarter 2026 Financial Results
IRVING, TX / ACCESS Newswire / August 5, 2026 / Envela Corporation today announced its financial results for the second quarter ended June 30, 2026. The Company reported quarterly revenue of $56.8 million and quarterly earnings per diluted share of $0.16.
Trustpoint Xposure, the First AEO-Certified PR Agency, Identifies Five AEO Misconceptions Costing Professional Brands AI Citation Authority
New research from Trustpoint Xposure documents the five beliefs about Answer Engine Optimization most consistently associated with poor AI citation outcomes across 200 professional audits.
NexTel Medical Corp. Executes Letter of Intent to Acquire 100% of Xycota Biosciences, LLC
Strategic Acquisition Positions NexTel at the Forefront of Precision Neuro-Restoration with Xycota's Breakthrough Exosome-Delivered Brain Circuitry Repair Platform and Pending FDA Orphan Drug Designation
Medical Care Technologies (OTCID:MDCE) Launches StrainScan Pro - Expanding AI Vision Platform into High-Value Agricultural & Food Quality Control Markets
New AI-Powered Platform Targets Multi-Trillion-Dollar Agriculture and Food Supply Chain Opportunities Through Advanced Visual Identification and Quality Monitoring
Kultura Brands Accelerates National Growth Strategy With the Appointment of Two Accomplished Beverage Industry Leaders
Former Reyes Beverage Group executive Chuck Voccio named Senior Operations Director. Award winning hospitality leader Stephen Wicker appointed Regional Sales Director, Southeast.
Becker Aesthetics & Plastic Surgery Highlights Personalized Approaches to Ethnic Rhinoplasty in Philadelphia
Becker Aesthetics & Plastic Surgery outlines how it tailors ethnic rhinoplasty to refine the nose while preserving the features that reflect each patient's heritage.
Maison Solutions Inc. Receives 2026 Global Recognition Award in Innovation Category
MONTEREY PARK, CA / ACCESS Newswire / August 5, 2026 / Maison Solutions Inc. (Nasdaq:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S. consumers, today announced that it has received a 2026 Global Recognition Award for its extraordinary achievements and pioneering contributions in the Specialty Grocery Retail industry.
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
As announced, Jaguar received an upfront payment of $16M of non-dilutive capital in January 2026 upon entering U.S. license agreement with Future Pak for Mytesi® and Canalevia®-CA1 - Jaguar's two commercialized crofelemer drugs - an agreement that is fully aligned with company's strategy to concentrate crofelemer development efforts on human rare-disease intestinal failure (IF) indicationsPresentation at ESPGHAN 2026 described additional groundbreaking results of evaluation of crofelemer as adjunctive oral therapy for the treatment of pediatric IF, which demonstrate reduction of parenteral support normalized to body weight of up to 48% in patient with the ultrarare microvillus inclusion disease (MVID)
Cerfinity Teams Up with SMC Consulting to Accelerate Platform and Brand Partnerships
Rob Rinderman and Darryl Haberman bring decades of corporate communications, digital marketing and enterprise business development experience as Cerfinity scales its Digital Provenance Technology platform
Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference
SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that management will host a booth at the Association of Diabetes Care & Education Specialists 2026 Annual Conference (the "Conference") in Columbus, Ohio, from August 7-10, 2026, where they will showcase the new Pivot tubeless insulin patch pump.
Food Culture Inc. to Present at the Emerging Growth Conference 95 on August 19, 2026
Presentation by Tim Chupinin, Investor Relations Consultant, Will Introduce the Company's Asset-Light Spirits Brand Platform, Current Operations, and Go-Forward Plans for the Balance of 2026 and Fiscal 2027; Live Webcast, Registration at No Cost
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
- A new chapter in skincare has arrived -- This will be Dermata's first commercial product launch, planned for August 25, 2026 -- Join the waitlist at tomeskincare.com -
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
A Positive First Half of 2026 Prompts the Company to Launch Its First Investor Call and Invite Shareholder Questions
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 05
LONDON, UK / ACCESS Newswire / August 5, 2026 / The Company announces that on 04 August 2026 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.